NorthWest Healthcare Properties REIT (NWHUF) Ratios
NorthWest Healthcare Properties REIT Ratios
NWHUF's free cash flow for Q2 2026 was $89.77M. For the 2026 fiscal year, NWHUF's free cash flow was decreased by $-207.00K and operating cash flow was $89.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.51 | 0.43 | 0.28 | 1.01 | 0.19 |
| Quick Ratio | 0.51 | 0.43 | 0.27 | 1.01 | 0.19 |
| Cash Ratio | 0.40 | 0.13 | 0.11 | 0.08 | 0.08 |
| Solvency Ratio | -0.03 | -0.09 | -0.08 | 0.05 | 0.22 |
| Operating Cash Flow Ratio | 0.69 | 0.22 | 0.16 | 0.20 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 0.69 | 0.33 | 0.23 | 0.44 | 0.20 |
| Net Current Asset Value | $ -1.82B | $ -3.30B | $ -4.36B | $ -3.66B | $ -3.40B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.40 | 0.50 | 0.51 | 0.43 | 0.42 |
| Debt-to-Equity Ratio | 0.92 | 1.93 | 1.97 | 1.50 | 1.23 |
| Debt-to-Capital Ratio | 0.48 | 0.66 | 0.66 | 0.60 | 0.55 |
| Long-Term Debt-to-Capital Ratio | 0.43 | 0.64 | 0.63 | 0.56 | 0.49 |
| Financial Leverage Ratio | 2.29 | 3.87 | 3.83 | 3.47 | 2.95 |
| Debt Service Coverage Ratio | 0.44 | -0.26 | -0.36 | 0.42 | 0.32 |
| Interest Coverage Ratio | 1.49 | 1.55 | 1.47 | 2.19 | 3.49 |
| Debt to Market Cap | 1.08 | 2.73 | 3.10 | 1.63 | 1.03 |
| Interest Debt Per Share | 6.12 | 13.03 | 17.02 | 16.20 | 14.73 |
| Net Debt to EBITDA | 7.42 | -17.60 | -14.59 | 9.99 | 8.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 70.24% | 75.56% | 76.11% | 77.61% | 81.70% |
| EBIT Margin | 44.33% | -37.20% | -52.20% | 82.17% | 223.76% |
| EBITDA Margin | 44.92% | -36.41% | -51.95% | 80.17% | 95.67% |
| Operating Profit Margin | 55.57% | 66.26% | 67.80% | 79.86% | 95.30% |
| Pretax Profit Margin | 7.07% | -79.95% | -98.23% | 45.66% | 196.49% |
| Net Profit Margin | -13.69% | -64.83% | -68.44% | 27.99% | 163.33% |
| Continuous Operations Profit Margin | 5.50% | -69.25% | -94.63% | 27.99% | 163.33% |
| Net Income Per EBT | -193.72% | 81.08% | 69.67% | 61.30% | 83.12% |
| EBT Per EBIT | 12.72% | -120.67% | -144.89% | 57.17% | 206.17% |
| Return on Assets (ROA) | -1.53% | -4.96% | -4.56% | 1.48% | 8.66% |
| Return on Equity (ROE) | -3.51% | -19.17% | -17.43% | 5.11% | 25.58% |
| Return on Capital Employed (ROCE) | 6.67% | 5.42% | 4.93% | 4.83% | 5.66% |
| Return on Invested Capital (ROIC) | 4.83% | 4.48% | 4.46% | 2.77% | 4.27% |
| Return on Tangible Assets | -1.53% | -5.03% | -4.61% | 1.49% | 8.77% |
| Earnings Yield | -4.15% | -27.33% | -27.60% | 5.57% | 21.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 25.04 | 30.41 | 13.04 | 11.57 | 5.10 |
| Payables Turnover | 1.59 | 1.08 | 0.94 | 0.75 | 0.76 |
| Inventory Turnover | 0.00 | 0.00 | 17.34 | 0.00 | -134.41 |
| Fixed Asset Turnover | 41.60 | 30.90 | 33.86 | 49.25 | 54.70 |
| Asset Turnover | 0.11 | 0.08 | 0.07 | 0.05 | 0.05 |
| Working Capital Turnover Ratio | -2.27 | -1.36 | -2.30 | -1.51 | -0.75 |
| Cash Conversion Cycle | -215.48 | -327.52 | -338.14 | -452.72 | -410.17 |
| Days of Sales Outstanding | 14.57 | 12.00 | 27.99 | 31.54 | 71.57 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 21.05 | 0.00 | -2.72 |
| Days of Payables Outstanding | 230.06 | 339.52 | 387.18 | 484.26 | 479.03 |
| Operating Cycle | 14.57 | 12.00 | 49.04 | 31.54 | 68.86 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.65 | 0.35 | 0.43 | 0.94 | 0.60 |
| Free Cash Flow Per Share | 0.64 | 0.35 | 0.43 | 0.94 | 0.60 |
| Dividend Paid and CapEx Coverage Ratio | 2.05 | 1.09 | 0.70 | 1.43 | 0.90 |
| Capital Expenditure Coverage Ratio | 84.99 | 98.24 | 1069.03 | 364.52 | 258.73 |
| Operating Cash Flow Coverage Ratio | 0.12 | 0.03 | 0.03 | 0.06 | 0.04 |
| Operating Cash Flow to Sales Ratio | 0.42 | 0.19 | 0.21 | 0.50 | 0.33 |
| Free Cash Flow Yield | 12.58% | 7.82% | 8.31% | 9.92% | 4.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.33 | -3.66 | -3.62 | 17.95 | 4.67 |
| Price-to-Sales (P/S) Ratio | 3.30 | 2.37 | 2.48 | 5.02 | 7.63 |
| Price-to-Book (P/B) Ratio | 0.84 | 0.70 | 0.63 | 0.92 | 1.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.95 | 12.79 | 12.04 | 10.08 | 22.95 |
| Price-to-Operating Cash Flow Ratio | 7.86 | 12.66 | 12.03 | 10.06 | 22.86 |
| Price-to-Earnings Growth (PEG) Ratio | 0.29 | 0.26 | 0.01 | -0.22 | 0.07 |
| Enterprise Value Multiple | 14.76 | -24.11 | -19.36 | 16.25 | 16.01 |
| Enterprise Value | 2.56B | 4.06B | 5.11B | 5.85B | 5.74B |
| EV to EBITDA | 14.76 | -24.11 | -19.36 | 16.25 | 16.01 |
| EV to Sales | 6.63 | 8.78 | 10.06 | 13.03 | 15.32 |
| EV to Free Cash Flow | 15.98 | 47.33 | 48.82 | 26.16 | 46.09 |
| EV to Operating Cash Flow | 15.79 | 46.85 | 48.77 | 26.09 | 45.92 |
| Tangible Book Value Per Share | 6.05 | 10.13 | 12.30 | 15.41 | 16.60 |
| Shareholders’ Equity Per Share | 6.05 | 6.34 | 8.17 | 10.35 | 11.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.13 | 0.04 | 0.39 | 0.17 |
| Revenue Per Share | 1.55 | 1.88 | 2.08 | 1.89 | 1.81 |
| Net Income Per Share | -0.21 | -1.22 | -1.42 | 0.53 | 2.96 |
| Tax Burden | -1.94 | 0.81 | 0.70 | 0.61 | 0.83 |
| Interest Burden | 0.16 | 2.15 | 1.88 | 0.56 | 0.88 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| SG&A to Revenue | 0.15 | 0.13 | 0.11 | 0.11 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | -0.01 | 0.00 | 0.03 |
| Income Quality | 7.64 | -0.27 | -0.22 | 1.78 | 0.20 |
Currency in CAD